questionsmedicales.fr
Techniques d'investigation
Techniques de chimie analytique
Chromatographie
Chromatographie en phase liquide
Chromatographie en phase liquide : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Chromatographie en phase liquide : Questions médicales les plus fréquentes",
"headline": "Chromatographie en phase liquide : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Chromatographie en phase liquide : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-16",
"dateModified": "2025-03-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Chromatographie en phase liquide"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Chromatographie",
"url": "https://questionsmedicales.fr/mesh/D002845",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie",
"code": {
"@type": "MedicalCode",
"code": "D002845",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromatographie d'affinité",
"alternateName": "Chromatography, Affinity",
"url": "https://questionsmedicales.fr/mesh/D002846",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie d'affinité",
"code": {
"@type": "MedicalCode",
"code": "D002846",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.170"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Purification par affinité en tandem",
"alternateName": "Tandem Affinity Purification",
"url": "https://questionsmedicales.fr/mesh/D000078791",
"about": {
"@type": "MedicalCondition",
"name": "Purification par affinité en tandem",
"code": {
"@type": "MedicalCode",
"code": "D000078791",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.170.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie sur gel",
"alternateName": "Chromatography, Gel",
"url": "https://questionsmedicales.fr/mesh/D002850",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie sur gel",
"code": {
"@type": "MedicalCode",
"code": "D002850",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromatographie sur agarose",
"alternateName": "Chromatography, Agarose",
"url": "https://questionsmedicales.fr/mesh/D002847",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie sur agarose",
"code": {
"@type": "MedicalCode",
"code": "D002847",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.250.200"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie en phase liquide à haute performance",
"alternateName": "Chromatography, High Pressure Liquid",
"url": "https://questionsmedicales.fr/mesh/D002851",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie en phase liquide à haute performance",
"code": {
"@type": "MedicalCode",
"code": "D002851",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie d'échange d'ions",
"alternateName": "Chromatography, Ion Exchange",
"url": "https://questionsmedicales.fr/mesh/D002852",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie d'échange d'ions",
"code": {
"@type": "MedicalCode",
"code": "D002852",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.383"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromatographie sur DEAE-cellulose",
"alternateName": "Chromatography, DEAE-Cellulose",
"url": "https://questionsmedicales.fr/mesh/D002848",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie sur DEAE-cellulose",
"code": {
"@type": "MedicalCode",
"code": "D002848",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.383.349"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie sur papier",
"alternateName": "Chromatography, Paper",
"url": "https://questionsmedicales.fr/mesh/D002854",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie sur papier",
"code": {
"@type": "MedicalCode",
"code": "D002854",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.454"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie en phase inverse",
"alternateName": "Chromatography, Reverse-Phase",
"url": "https://questionsmedicales.fr/mesh/D056148",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie en phase inverse",
"code": {
"@type": "MedicalCode",
"code": "D056148",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.495"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromatographie sur couche mince",
"alternateName": "Chromatography, Thin Layer",
"url": "https://questionsmedicales.fr/mesh/D002855",
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie sur couche mince",
"code": {
"@type": "MedicalCode",
"code": "D002855",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.196.181.400.537"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Chromatographie en phase liquide",
"alternateName": "Chromatography, Liquid",
"code": {
"@type": "MedicalCode",
"code": "D002853",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mirjana Minceva",
"url": "https://questionsmedicales.fr/author/Mirjana%20Minceva",
"affiliation": {
"@type": "Organization",
"name": "Biothermodynamics, TUM School of Life Sciences Weihenstephan, Technical University of Munich, Maximus-von-Imhof-Forum 2, 85354 Freising, Germany. Electronic address: mirjana.minceva@tum.de."
}
},
{
"@type": "Person",
"name": "Melanie Gerigk",
"url": "https://questionsmedicales.fr/author/Melanie%20Gerigk",
"affiliation": {
"@type": "Organization",
"name": "Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, 85354 Freising, Germany."
}
},
{
"@type": "Person",
"name": "Simon Vlad Luca",
"url": "https://questionsmedicales.fr/author/Simon%20Vlad%20Luca",
"affiliation": {
"@type": "Organization",
"name": "Biothermodynamics, TUM School of Life Sciences, Technical University of Munich, 85354 Freising, Germany."
}
},
{
"@type": "Person",
"name": "Shengqiang Tong",
"url": "https://questionsmedicales.fr/author/Shengqiang%20Tong",
"affiliation": {
"@type": "Organization",
"name": "College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, 310032, China. Electronic address: sqtong@zjut.edu.cn."
}
},
{
"@type": "Person",
"name": "Gert Desmet",
"url": "https://questionsmedicales.fr/author/Gert%20Desmet",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemical Engineering, Vrije Universiteit Brussel, Pleinlaan 2, B-1050 Brussel, Belgium."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Virgaricins C and D, new pramanicin analogs produced by Apiospora sp. FKI-8058.",
"datePublished": "2024-02-02",
"url": "https://questionsmedicales.fr/article/38302743",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41429-023-00699-8"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evidence for the elimination of viral hepatitis B and C in Egypt: Results of a nationwide survey in 2022.",
"datePublished": "2024-01-30",
"url": "https://questionsmedicales.fr/article/38291807",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/liv.15843"
}
},
{
"@type": "ScholarlyArticle",
"name": "The identification of c-Abl inhibitors as potential agents for Parkinson's disease: a preliminary in silico approach.",
"datePublished": "2024-01-25",
"url": "https://questionsmedicales.fr/article/38273156",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11030-023-10796-3"
}
},
{
"@type": "ScholarlyArticle",
"name": "On-Demand Generation of Indistinguishable Photons in the Telecom C-Band Using Quantum Dot Devices.",
"datePublished": "2024-01-23",
"url": "https://questionsmedicales.fr/article/38405394",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1021/acsphotonics.3c00973"
}
},
{
"@type": "ScholarlyArticle",
"name": "ANP32B inhibition suppresses the growth of prostate cancer cells by regulating c-Myc signaling.",
"datePublished": "2024-01-17",
"url": "https://questionsmedicales.fr/article/38266312",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbrc.2024.149543"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de chimie analytique",
"item": "https://questionsmedicales.fr/mesh/D002623"
},
{
"@type": "ListItem",
"position": 4,
"name": "Chromatographie",
"item": "https://questionsmedicales.fr/mesh/D002845"
},
{
"@type": "ListItem",
"position": 5,
"name": "Chromatographie en phase liquide",
"item": "https://questionsmedicales.fr/mesh/D002853"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Chromatographie en phase liquide - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Chromatographie en phase liquide",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Chromatographie en phase liquide",
"description": "Comment la chromatographie en phase liquide est-elle utilisée en diagnostic ?\nQuels types d'échantillons peuvent être analysés ?\nQuels sont les avantages de cette méthode pour le diagnostic ?\nPeut-on utiliser cette technique pour des médicaments ?\nLa chromatographie en phase liquide peut-elle détecter des toxines ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Chromatographie en phase liquide",
"description": "Quels symptômes peuvent indiquer un besoin d'analyse par chromatographie ?\nLa chromatographie peut-elle aider à diagnostiquer des allergies ?\nQuels symptômes sont liés à des déséquilibres hormonaux ?\nPeut-on détecter des maladies métaboliques avec cette technique ?\nQuels symptômes peuvent indiquer une intoxication médicamenteuse ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Chromatographie en phase liquide",
"description": "Comment la chromatographie contribue-t-elle à la prévention des maladies ?\nPeut-on utiliser cette technique pour le dépistage précoce ?\nQuels programmes de santé publique utilisent la chromatographie ?\nLa chromatographie peut-elle aider à prévenir les intoxications ?\nComment cette technique aide-t-elle à la recherche en santé publique ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Chromatographie en phase liquide",
"description": "La chromatographie en phase liquide est-elle utilisée dans le traitement ?\nComment cette technique aide-t-elle à ajuster les traitements ?\nPeut-on utiliser la chromatographie pour évaluer l'efficacité d'un traitement ?\nQuels traitements peuvent être surveillés par cette méthode ?\nLa chromatographie peut-elle aider à détecter des effets secondaires ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Chromatographie en phase liquide",
"description": "Quelles complications peuvent survenir lors de l'utilisation de cette technique ?\nLa chromatographie peut-elle causer des effets indésirables ?\nQuels risques sont associés à l'échantillonnage ?\nComment minimiser les complications lors de l'analyse ?\nLes résultats erronés peuvent-ils entraîner des complications cliniques ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Chromatographie en phase liquide",
"description": "Quels facteurs de risque influencent l'analyse par chromatographie ?\nL'âge peut-il être un facteur de risque pour certaines analyses ?\nLes habitudes alimentaires affectent-elles les résultats ?\nLe mode de vie peut-il impacter les résultats d'analyse ?\nLes médicaments pris peuvent-ils influencer les résultats ?",
"url": "https://questionsmedicales.fr/mesh/D002853?mesh_terms=Lectins,+C-Type&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment la chromatographie en phase liquide est-elle utilisée en diagnostic ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'analyser des échantillons biologiques pour détecter des substances spécifiques."
}
},
{
"@type": "Question",
"name": "Quels types d'échantillons peuvent être analysés ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des échantillons de sang, d'urine, de tissus et d'autres fluides biologiques."
}
},
{
"@type": "Question",
"name": "Quels sont les avantages de cette méthode pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle offre une haute résolution et une grande sensibilité pour détecter des analytes."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser cette technique pour des médicaments ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est couramment utilisée pour analyser des médicaments dans le plasma."
}
},
{
"@type": "Question",
"name": "La chromatographie en phase liquide peut-elle détecter des toxines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est efficace pour identifier des toxines dans divers échantillons."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un besoin d'analyse par chromatographie ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes inexpliqués, intoxications ou réactions indésirables aux médicaments."
}
},
{
"@type": "Question",
"name": "La chromatographie peut-elle aider à diagnostiquer des allergies ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut identifier des allergènes dans des échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des déséquilibres hormonaux ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, changements de poids, et irrégularités menstruelles peuvent être des indicateurs."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des maladies métaboliques avec cette technique ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'analyser des métabolites pour diagnostiquer des maladies métaboliques."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une intoxication médicamenteuse ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Nausées, vomissements, confusion et troubles respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment la chromatographie contribue-t-elle à la prévention des maladies ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de détecter précocement des biomarqueurs de maladies, facilitant l'intervention."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser cette technique pour le dépistage précoce ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle est utilisée pour le dépistage de maladies comme le diabète et le cancer."
}
},
{
"@type": "Question",
"name": "Quels programmes de santé publique utilisent la chromatographie ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des programmes de dépistage des drogues et de surveillance des maladies infectieuses."
}
},
{
"@type": "Question",
"name": "La chromatographie peut-elle aider à prévenir les intoxications ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'analyser des aliments et des médicaments pour détecter des contaminants."
}
},
{
"@type": "Question",
"name": "Comment cette technique aide-t-elle à la recherche en santé publique ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet d'analyser des échantillons pour étudier l'épidémiologie des maladies."
}
},
{
"@type": "Question",
"name": "La chromatographie en phase liquide est-elle utilisée dans le traitement ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, elle aide à surveiller les niveaux de médicaments dans le sang."
}
},
{
"@type": "Question",
"name": "Comment cette technique aide-t-elle à ajuster les traitements ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle permet de mesurer la concentration des médicaments pour optimiser les doses."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser la chromatographie pour évaluer l'efficacité d'un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet de quantifier les biomarqueurs et les médicaments dans le corps."
}
},
{
"@type": "Question",
"name": "Quels traitements peuvent être surveillés par cette méthode ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements pour le cancer, les maladies infectieuses et les troubles psychiatriques."
}
},
{
"@type": "Question",
"name": "La chromatographie peut-elle aider à détecter des effets secondaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut identifier des métabolites associés à des effets indésirables."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir lors de l'utilisation de cette technique ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des erreurs d'analyse peuvent mener à des diagnostics erronés ou à des traitements inappropriés."
}
},
{
"@type": "Question",
"name": "La chromatographie peut-elle causer des effets indésirables ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, elle est une méthode analytique et ne cause pas d'effets indésirables directs."
}
},
{
"@type": "Question",
"name": "Quels risques sont associés à l'échantillonnage ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des risques d'infection ou de complications liées à la collecte d'échantillons biologiques."
}
},
{
"@type": "Question",
"name": "Comment minimiser les complications lors de l'analyse ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "En suivant des protocoles stricts de manipulation et d'analyse des échantillons."
}
},
{
"@type": "Question",
"name": "Les résultats erronés peuvent-ils entraîner des complications cliniques ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des résultats incorrects peuvent mener à des traitements inappropriés et à des complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque influencent l'analyse par chromatographie ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "La qualité des échantillons, la technique utilisée et l'expérience de l'opérateur."
}
},
{
"@type": "Question",
"name": "L'âge peut-il être un facteur de risque pour certaines analyses ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies sont plus fréquentes chez les personnes âgées, influençant les résultats."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires affectent-elles les résultats ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'alimentation peut influencer les niveaux de métabolites détectés dans les échantillons."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il impacter les résultats d'analyse ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme, l'alcool et d'autres facteurs de mode de vie peuvent affecter les résultats."
}
},
{
"@type": "Question",
"name": "Les médicaments pris peuvent-ils influencer les résultats ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains médicaments peuvent interférer avec les analyses et fausser les résultats."
}
}
]
}
]
}
Two new pramanicin analogs, named virgaricins C (1) and D (2), were discovered by physicochemical screening from a static cultured material of Apiospora sp. FKI-8058. Their structures were elucidated ...
Viral hepatitis C (HCV) and B (HBV) were at the top of Egypt's most significant public health challenges, with an estimated 14.7% of its population having antibodies to HCV in 2008. Egypt issued an am...
A cross-sectional household cluster survey was conducted in all 27 Egyptian governorates to obtain a representative sample of Egypt's population. Subjects aged 1-70 years were interviewed using a stan...
Of 20 881 subjects interviewed, 48.8% were males, 20.2% were children <15 years of age, and 53.7% were residents of rural areas. Of all subjects, 92 (0.4%) were HCV-infected, 1577 (7.6%) were anti-HCV...
Egypt achieved the elimination of the viral hepatitis goal. To maintain low rates of viral hepatitis, community health education, in addition to maintaining infection control and blood safety programs...
Parkinson's disease (PD) is the most common movement disorder worldwide. PD is primarily associated with the mutation, overexpression, and phosphorylation of α-synuclein. At the molecular level, the u...
Semiconductor quantum dots (QDs) enable the generation of single and entangled photons, which are useful for various applications in photonic quantum technologies. Specifically for quantum communicati...
ANP32B is a histone chaperone that interacts with various transcription factors that regulate cancer cell proliferation, immigration, and apoptosis. c-Myc, a well-known oncogenic protein, is a princip...
Gene regulation in changing environments is critical for maintaining homeostasis. Some animals undergo a stress-resistant diapause stage to withstand harsh environmental conditions encountered during ...
Hepatocarcinogenesis is a multi-step process. However, the regulators of hepatocellular carcinoma (HCC) initiation are understudied. Adult liver-specific gene expression was globally downregulated in ...
Sensitivity to pain traumatization is defined as the propensity to develop cognitive, affective, and behavioral responses to pain that resemble a traumatic stress reaction. To date, sensitivity to pai...
This prospective study aimed to adapt the SPTS-12 for use in youth and to evaluate the psychometric properties of the new scale....
Participants included 175 youth with chronic pain (...
The SPTS-C had a one-factor structure that explained 48% of variance and demonstrated good reliability and construct validity. SPTS-C baseline scores predicted follow-up levels of pain interference bu...
The results provide preliminary evidence for the psychometric properties of the SPTS-C and the potential role of SPT in pediatric chronic pain outcomes....
Oxosorbicillinol and cage-like acresorbicillinol C are bioactive sorbicillinoids produced by...
Hypozincemia is a prevalent adverse consequence in diabetes mellitus (DM) and β-Thalassemia patients. We aimed to evaluate the level of serum zinc in β-thalassemia patients with DM and a risk assessme...
The study population included transfusion-dependent thalassemia (TDT) and non-transfusion-dependent thalassemia (NTDT) with overt DM (fasting plasma glucose (FPG) ≥126 mg/dL, and/or 2-h plasma glucose...
Of 64 diabetic β-thalassemia patients, 41 cases had zinc data in their medical files (aged 38 ± 9 years, 48.8% female). 78.05% of patients (n = 32) were TDT, and 21.95% were NTDT (n = 9). The mean ± s...
In light of this study, as well as hepatitis C, using DFX and antacids is associated with a high risk of hypozincemia amid diabetic β-thalassemia cases. However, upward bias should be taken into consi...